First Manhattan’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1691 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1695 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1713 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1709 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1708 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1642 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1578 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1431 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1491 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1496 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1484 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1392 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1422 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1461 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1474 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1456 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1456 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1437 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1481 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1536 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1512 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1489 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | -$705 | – | 1469 |
|
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1464 |
|
|
2016
Q3 | $0 | Sell |
1
-1
| -50% | -$1.26K | ﹤0.01% | 1478 |
|
|
2016
Q2 | $3K | Hold |
2
| – | – | ﹤0.01% | 1383 |
|
|
2016
Q1 | $2K | Hold |
2
| – | – | ﹤0.01% | 1341 |
|
|
2015
Q4 | $2K | Hold |
2
| – | – | ﹤0.01% | 1355 |
|
|
2015
Q3 | $3K | Hold |
2
| – | – | ﹤0.01% | 1322 |
|
|
2015
Q2 | $4K | Hold |
2
| – | – | ﹤0.01% | 1328 |
|
|
2015
Q1 | $6K | Hold |
2
| – | – | ﹤0.01% | 1287 |
|
|
2014
Q4 | $7K | Hold |
2
| – | – | ﹤0.01% | 1290 |
|
|
2014
Q3 | $6K | Hold |
2
| – | – | ﹤0.01% | 1282 |
|
|
2014
Q2 | $7K | Hold |
2
| – | – | ﹤0.01% | 1243 |
|
|
2014
Q1 | $7K | Hold |
2
| – | – | ﹤0.01% | 1234 |
|
|
2013
Q4 | $7K | Hold |
2
| – | – | ﹤0.01% | 1206 |
|
|
2013
Q3 | $7K | Hold |
2
| – | – | ﹤0.01% | 1207 |
|
|
2013
Q2 | $20K | Buy |
+2
| New | +$22.2K | ﹤0.01% | 1070 |
|
Other funds holding FRTX
TI
PCM
TSS
TRCT
BTI
First Manhattan's FRTX Position: Q3 2022 in Review
First Manhattan held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1691.
First Manhattan first reported a position in FRTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $20K in Q2 2013. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2022.
- First Manhattan held 0 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $0 as of Q3 2022.
- First Manhattan left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q3 2022.
- Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of First Manhattan's portfolio in Q3 2022, its #1691 holding.
- First Manhattan first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
- First Manhattan's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $20K in Q2 2013.
- 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2022.
Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.